Hey, everybody. It's me, Sam Stein, managing editor at The Bullwork, and I am here on Tuesday afternoon.

I'm going to be talking about something that I've talked about a couple times with you all.

A bill that's been something that I've taken on as a hobby horse in terms of my coverage that I've written about several times, and that's kind of been central to a few of

these videos that we've done. It's called the Give Kids a Chance Act. You might remember this

is sort of a monumental piece of pediatric cancer legislation. It's been considered by Congress

at several junctures throughout the past 13 or so months.

And for some reason or other, it has never passed.

It's had these gut-wrenching awful defeats, sometimes inexplicable defeats,

despite being like the third most co-sponsored bill in Congress with no one actually objecting to it.

It never made it into law. And then. It never made it into law.

And then today, it made it into law.

It actually passed.

And as I am doing this, the bill is likely to be signed into law by President Trump.

It's a pretty remarkable moment in this field of pediatric cancer research.

And I want to take a moment to reflect on it.

So you might be saying, well, what does the bill do?

I'm not a doctor.

I'm not a scientist.

I've confessed that on these programs before.

But this bill would allow for the study of combination drug therapies for kids suffering with cancer right now. That's really not an option for many of these kids. This would

make it so that the FDA would allow for those combination drug therapy treatments to be studied.

In addition, it would open up some funnels of money for pediatric cancer research,

...